"Schizotaxia": Clinical implications and new directions for research

Schizophrenia Bulletin

Volumn 27, Issue 1, 2001, Pages 1-18

  Faraone, Stephen V ^a   Green, Alan I ^a   Seidman, Larry J ^a   Tsuang, Ming T ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Genetics; Prevention; Schizophrenia; Schizotaxia; Spectrum

Indexed keywords

ALERTNESS; CLINICAL RESEARCH; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC VALUE; DISEASE PREDISPOSITION; FAMILY LIFE; HUMAN; HUMAN CELL; HUMAN TISSUE; PERSONALITY DISORDER; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SCHIZOTAXIA; SHORT TERM MEMORY;

EID: 0035097867     PISSN: 05867614     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.schbul.a006849     Document Type: Review

References (146)

1. Thought disorder in children at risk for psychosis
2. Children at risk for schizophrenia: Converging lines of evidence
3. Schizophrenia during adolescence and early adulthood: A developmental perspective on risk research
4. An attentional assessment of foster children at risk for schizophrenia
5. Neurobehavioral functioning and social behavior of children at risk for schizophrenia
6. A family study of schizotypal disorder
7. Review article schizotypal disorder: At the crossroads of genetics and nosology
8. Olanzapine versus placebo: Results of a double-blind, fixed-dose olanzapine trial
9. The multidimensional nature of schizotypal traits: A factor analytic study with normal subjects
10. Neuropsychological functioning in siblings discordant for Schizophrenia and healthy volunteers
11. Patient response and resource management: Another view of clozapine treatment with schizophrenia
12. Spontaneous dyskinesias in subjects with schizophrenia spectrum personality disorders
13. Allusive thinking in parents of schizophrenics: Meta-analysis
14. Schizotypy in community samples: The three-factor structure and correlation with sustained attention
15. Schizotypal personality disorder in individuals with and without schizophrenic relatives: Similarities and contrasts in neurocognitive and clinical functioning
16. Global attentional deviance as a marker of risk for schizophrenia: Specificity and predictive validity
17. Impaired attention, genetics, and the pathophysiology of schizophrenia
18. Parental communication deviance and affective style: Predictors of subsequent schizophrenia-spectrum disorders in vulnerable adolescents
19. Communication deviance, attention, and schizotypy in parents of schizophrenic patients
20. Cognitive characteristics of the parents of schizophrenic patients
21. Affective reactivity of cognitive functioning and family history in schizophrenia
22. DSM-III-R personality disorders in parents of schizophrenic patients
23. Intentional and incidental learning in children vulnerable to psychopathology
24. Social competence deficits in adolescents at risk for schizophrenia
25. Childhood precursors of affective vs. social deficits in adolescents at risk for schizophrenia
26. Neurological, electrophysiological, and attentional deviations in children at risk for schizophrenia
27. Family management in the prevention of morbidity of schizophrenia. Clinical outcome of a two-year controlled study
28. Early detection and intervention for initial episodes of schizophrenia
29. Gender differences in the age at onset of schizophrenia: Fact or artifact
30. Diagnostic accuracy and linkage analysis: How useful are schizophrenia spectrum phenotypes?
31. A genome scan of the European-American schizophrenia pedigrees of the NIMH Genetics Initiative
32. Neuropsychological functioning among the nonpsychotic relatives of schizophrenic patients: A diagnostic efficiency analysis
33. Neuropsychological functioning among the nonpsychotic relatives of schizophrenic patients: A four-year follow-up study
34. Measuring diagnostic accuracy in the absence of a gold standard
35. Visual-motor disorders in infants at risk for schizophrenia
36. Infants at risk for schizophrenia: Sequelae of a genetic neurointegrative defect. A review and replication analysis of pandysmaturation in the Jerusalem infant development study
37. Wisconsin Card Sorting Test: An indicator of vulnerability to schizophrenia?
38. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus
39. Event-related potentials (ERPs) as indicators of risk for schizophrenia
40. Neuropsychological assessment of monozygotic twins discordant for schizophrenia
41. The UCLA high-risk project
42. Should clozapine be a first-line treatment for schizophrenia? The rationale for a double-blind clinical trial in first-episode patients
43. What are the functional consequences of neurocognitive deficits in schizophrenia?
44. Does risperidone improve verbal working memory in treatment-resistant schizophrenia?
45. Familial prevalence and coaggregation of schizotypy indicators: A multitrait family study
46. The search for a schizotype: Crossing the border again
47. Interpersonal behavior of children at risk for schizophrenia
48. Distractibility in children vulnerable to psychopathology
49. The factor structure of schizotypy in a normal population
50. Neuroleptic treatment of schizotypal personality disorders
51. Neurological abnormalities in schizophrenic patients and their siblings
52. Frontal functioning and plasma HVA in the relatives of schizophrenic patients
53. Performance of nonpsychotic relatives of schizophrenic patients on cognitive tests
54. Diagnostic approaches to schizotypal personality disorder: A historical perspective
55. The Roscommon family study: III. Schizophrenia-related personality disorders in relatives
56. Schizotypal symptoms and signs in the Roscommon family study
57. The structure of schizotypy: A pilot multitrait twin study
58. Mental illness in the biological and adoptive relatives of schizophrenic adoptees: Replication of the Copenhagen study in the rest of Denmark
59. Neurological abnormalities in schizophrenic patients and their families: II. Neurologic and psychiatric findings in relatives
60. Hard neurologic signs and psychopathology in relatives of schizophrenic patients
61. Neuropsychological risk indicators for schizophrenia: A review of family studies
62. The influence of psychotic parents on their children's development
63. Recent developments in high risk research
64. Further investigation of a chromosome 15 locus in schizophrenia: Analysis of affected sibpairs from the NIMH Genetics Initiative
65. Eye tracking and schizophrenia: A selective review
66. Thought disorders in the parents of schizophrenic patients: A study utilizing the object sorting test
67. Atypical antipsychotic drugs as a firstline treatment of schizophrenia: A rationale and hypothesis
68. Perceptualmotor and memory performance of high-risk children
69. Psychopathological and neuropsychological profile of clozapine vs. risperidone in refractory schizophrenics
70. A comparison of schizotypal relatives of schizophrenic versus affective probands
71. Verbal learning and memory in relatives of schizophrenics: Preliminary findings
72. Personality disorders among the relatives of schizophrenia patients
73. Personality variations in healthy relatives of schizophrenics
74. Risperidone in the treatment of schizophrenia
75. Thought disorder or allusive thinking in the relatives of schizophrenics? A response to Callahan, Madsen, Saccuzzo, and Romney
76. Early detection and intervention in schizophrenia: Research
77. Early detection and intervention with schizophrenia: Rationale
78. EPPIC: An evolving system of early detection and optimal management
79. The genetics of personality disorder
80. Some premorbid characteristics related to breakdown in children with schizophrenic mothers
81. Schizotaxia, schizotypy, schizophrenia
82. Schizotaxia revisited
83. Clozapine: Is another view valid?
84. Family risk indicators in schizophrenia
85. On familial factors in the attentional deficit in schizophrenia: A review and report of two new subject samples
86. Measuring liability to schizophrenia: Progress report 1994: Editor's introduction
87. Remediation of neuropsychological impairments with clozapine
88. Personality dimensions, schizotypal and borderline personality traits, and psychosis proneness
89. Information processing and attentional functioning in the developmental course of schizophrenic disorders
90. Risk factors of psychosis: Identifying vulnerable populations premorbidly
91. The children of psychiatrically disturbed parents: Differences as a function of the sex of the sick parent
92. Spatial working memory deficits in the relatives of schizophrenic patients
93. Neuropsychological impairments are increased in siblings of schizophrenic patients
94. Neuropsychological impairments among siblings of schizophrenic probands
95. Clozapine enhances neurocognition and clinical symptoms more than standard neuroleptics
96. Schizophrenia: Age at onset, gender and familial risk
97. Sequential strategy to identify a susceptibility gene for schizophrenia on chromosome 22q12-q13.1: Part 1
98. Factors of schizoid personality
99. Cognitive-perceptual, interpersonal, and disorganized features of schizotypal personality
100. Thought disorder in the relatives of schizophrenics: A meta-analytic review of selected published studies
101. Maintenance of grip-induced muscle tension: A behavioral marker for schizophrenia
102. Thought disorders in the parents of schizophrenic patients: A further study using the object sorting test
103. Neuropsychological and P300 abnormalities in schizophrenics and their relatives
104. Communication deviance in parental schizophrenics
105. The relationship between psychosocial and cognitive functioning in schizophrenic patients and expressed emotion and communication deviance in their parents
106. Thought disorder and associative cognitive dysfunction in the first degree relatives of adult schizophrenics: A reply to Romney
107. A combined analysis of D22S278 marker alleles in affected sib-pairs: Support for a susceptibility locus at chromosome 22q12
108. Additional support for schizophrenia linkage on chromosomes 6 and 8: A multicenter study
109. Thought disorders in parents of psychotic children
110. Further evidence for a susceptibility locus on chromosome 10p14-p11 in 72 families with schizophrenia by non-parametric linkage analysis
111. Listening, meaning, and empathy in neuropsychological disorders: Case examples of assessment and treatment
112. Clinical neuroscience and epidemiology in schizophrenia
113. Reduced subcortical brain volumes in nonpsychotic siblings of schizophrenic patients: A pilot MRI study
114. Age at onset, sex, and familial psychiatric morbidity in schizophrenia: Camberwell collaborative psychosis study
115. Thought disorder in the relatives of psychotic patients
116. Biological markers in schizotypal personality disorder
117. Thought disorder and family relations of schizophrenics: III. Methodology using projective techniques
118. Quetiapine in patients with schizophrenia: A high- and low-dose double-blind comparison with placebo: Seroquel Study Group
119. Positive and negative symptoms and children at risk for schizophrenia
120. Personality and neuropsychological performance of high-risk children
121. Distractibility as a marker of vulnerability to schizophrenia
122. DSM-III-R schizotypal personality traits in offspring of schizophrenic disorder, affective disorder, and normal control parents
123. The assessment of schizotypal features over two points in time
124. Effects of clozapine on cognitive functions in treatment-refractory schizophrenia
125. A schizophrenia locus may be located in region 10p15-p11
126. A potential vulnerability locus for schizophrenia on chromosome 6p24-22: Evidence for genetic heterogeneity
127. Psychiatric illnesses in families of subjects with schizophrenia-spectrum personality disorders: High morbidity risks for unspecified functional psychoses and schizophrenia
128. Psychosis proneness scales in schizophrenia spectrum personality disorders: Familial vs. nonfamilial samples
129. Eye movements in spectrum personality disorders: Comparison of community subjects and relatives of schizophrenic patients
130. Poor perception of nonverbal social emotional cues in relatives of schizophrenic patients: An attentional deficit?
131. Relationship of schizotypal personality disorder to schizophrenia: Genetics
132. "True" schizotypal personality disorder: A study of co-twins and relatives of schizophrenic probands
133. The case for heterogeneity in the etiology of schizophrenia
134. Genetic transmission of negative and positive symptoms in the biological relatives of schizophrenics
135. Earlier detection and intervention in schizophrenia: Unsolved questions
136. Longitudinal analysis of communication deviance in the families of schizophrenic patients
137. Can communication deviance be measured in a family problem-solving interaction?
138. The relationship between parental communication deviance and relapse in schizophrenic patients in the 1-year period after hospital discharge: A pilot study
139. Prediction of adult-onset schizophrenia from childhood home movies of the parents
140. Evidence for a susceptibility locus for schizophrenia on chromosome 6pter-p22
141. Cognitive and attentional deficits in children vulnerable to psychopathology
142. The intelligence of children and their parents with schizophrenia and affective illness
143. Early intervention for schizophrenia: Can the course of the illness be altered?
144. Thought disorder and family relations of schizophrenics: I. A research strategy
145. Thought disorder and family relations of schizophrenics: II. A classification of forms of thinking
146. Monitoring and care of young people at incipient risk of psychosis